United States S 2199: Insulin Price Reduction Act

Status: Introduced in Senate (as of 2019-07-22)

State: United States · Session: 116 · Bill: S 2199

Subjects: Accounting and auditing, Business records, Digestive and metabolic diseases, Drug safety, medical device, and laboratory regulation, Fraud offenses and financial crimes, Health care costs and insurance, Health programs administration and funding, Inflation and prices, Medicare, Prescription drugs

Sponsors: Jeanne Shaheen, Kevin Cramer, SUSAN MARGARET COLLINS, THOMAS R. CARPER

View United States S 2199 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.